Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 24 Carboplatin 18 Bevacizumab 14 Cisplatin 12 pembrolizumab 7 fluzoparib 7 Drug Therapy 7 Radiotherapy 6 camrelizumab 5 apatinib 5 Topotecan 5 Magnetic Resonance Spectroscopy 5 Injections 5 liposomal doxorubicin 4 lenvatinib 4 famitinib 4 Tirzepatide 4 Specimen Handling 4 Platinum 4 Observation 4 Gemcitabine 4 Brachytherapy 4 toripalimab 3 olaparib 3 dostarlimab 3 anlotinib 3 Watchful Waiting 3 Therapeutics 3 Surveys and Questionnaires 3 Neoadjuvant Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Biosimilar Pharmaceuticals × Gynecologic × Clear all

NCT06650709 2024-10-23

NEOCATS

British Columbia Cancer Agency

Phase 2 Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡